BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7906414)

  • 1. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
    Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
    Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.
    Stein CA; Neckers LM; Nair BC; Mumbauer S; Hoke G; Pal R
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):686-93. PubMed ID: 1711118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
    Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azasugar-containing phosphorothioate oligonucleotide (AZPSON) DBM-2198 inhibits human immunodeficiency virus type 1 (HIV-1) replication by blocking HIV-1 gp120 without affecting the V3 region.
    Lee J; Byeon SE; Jung JY; Kang MH; Park YJ; Jung KE; Bae YS
    Mol Cells; 2015; 38(2):122-9. PubMed ID: 25623024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydeoxyguanine motifs in a 12-mer phosphorothioate oligodeoxynucleotide augment binding to the v3 loop of HIV-1 gp120 and potency of HIV-1 inhibition independency of G-tetrad formation.
    Lederman S; Sullivan G; Benimetskaya L; Lowy I; Land K; Khaled Z; Cleary AM; Yakubov L; Stein CA
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):281-9. PubMed ID: 9012864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of phosphorothioate analogues of oligodeoxyribonucleotides and their antiviral activity against human immunodeficiency virus (HIV).
    Matsukura M; Zon G; Shinozuka K; Stein CA; Mitsuya H; Cohen JS; Broder S
    Gene; 1988 Dec; 72(1-2):343-7. PubMed ID: 3243433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
    Agrawal S; Tang JY
    Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378
    [No Abstract]   [Full Text] [Related]  

  • 9. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
    Delézay O; Hammache D; Fantini J; Yahi N
    Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of inhibition of HIV-1 infection in vitro by guanine-rich oligonucleotides modified at the 5' terminal by dimethoxytrityl residue.
    Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
    Nucleic Acids Res; 1994 Dec; 22(25):5621-7. PubMed ID: 7530843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a phosphodiester hexanucleotide that inhibits HIV-1 infection in vitro on covalent linkage of its 5'-end with a dimethoxytrityl residue.
    Furukawa H; Momota K; Agatsuma T; Yamamoto I; Kimura S; Shimada K
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):167-75. PubMed ID: 9212907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320.
    Stoddart CA; Rabin L; Hincenbergs M; Moreno M; Linquist-Stepps V; Leeds JM; Truong LA; Wyatt JR; Ecker DJ; McCune JM
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2113-5. PubMed ID: 9687417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Düzgünes N
    Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of G-quartet-mediated tetramer formation.
    Wyatt JR; Davis PW; Freier SM
    Biochemistry; 1996 Jun; 35(24):8002-8. PubMed ID: 8672504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abasic oligodeoxyribonucleoside phosphorothioates: synthesis and evaluation as anti-HIV-1 agents.
    Iyer RP; Uznanski B; Boal J; Storm C; Egan W; Matsukura M; Broder S; Zon G; Wilk A; Koziolkiewicz M
    Nucleic Acids Res; 1990 May; 18(10):2855-9. PubMed ID: 2349087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.
    Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide.
    Bishop JS; Guy-Caffey JK; Ojwang JO; Smith SR; Hogan ME; Cossum PA; Rando RF; Chaudhary N
    J Biol Chem; 1996 Mar; 271(10):5698-703. PubMed ID: 8621435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1.
    Farooqui F; Sarin PS; Sun D; Letsinger RL
    Bioconjug Chem; 1991; 2(6):422-6. PubMed ID: 1805939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus 1 replication in vitro by a self-stabilized oligonucleotide with 2'-O-methyl-guanosine-uridine quadruplex motifs.
    Kuwasaki T; Hatta M; Takeuchi H; Takaku H
    J Antimicrob Chemother; 2003 Apr; 51(4):813-9. PubMed ID: 12654739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorothioate hammerhead ribozymes targeting a conserved sequence in the V3 loop region inhibit HIV-1 entry.
    Zhang X; Iwatani Y; Shimayama T; Yamada R; Koito A; Xu Y; Sakai H; Uchiyama T; Hattori T
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):441-50. PubMed ID: 9918108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.